{"slug":"astellas-pharma","name":"아스텔라스제약","name_en":"Astellas Pharma","ticker":"4503.T","updated_at":"2026-07-11T10:20:50.85+00:00","canonical":"https://valuechain.wiki/astellas-pharma","kicker":"닛케이 225","kicker_en":"Nikkei 225","lead":"비뇨기와 종양 분야에 강한 일본 2위권 제약사로 신약 개발과 글로벌 판매를 한다. 닛케이 225 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"Astellas Pharma is a top-tier Japanese drugmaker strong in urology and oncology with global reach. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"종양(항암제)"},{"name":"비뇨기·이식"},{"name":"기타 의약품"}],"total":"약 ¥1.6조 (FY2024)"},"segments_en":{"parts":[{"name":"Oncology"},{"name":"Urology and transplant"},{"name":"Other pharmaceuticals"}],"total":"~¥1.6T (FY2024)"},"returns_yearly":{"2021":12.2,"2022":6.4,"2023":-6.9,"2024":-8.4,"2025":48.7,"2026":1.4},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}